Literature DB >> 35582047

BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons.

Ruitao Lin1, Peter F Thall1, Ying Yuan1.   

Abstract

A Bayesian group sequential design is proposed that performs survival comparisons within patient subgroups in randomized trials where treatment-subgroup interactions may be present. A latent subgroup membership variable is assumed to allow the design to adaptively combine homogeneous subgroups, or split heterogeneous subgroups, to improve the procedure's within-subgroup power. If a baseline covariate related to survival is available, the design may incorporate this information to improve subgroup identification while basing the comparative test on the average hazard ratio. General guidelines are provided for calibrating prior hyperparameters and design parameters to control the overall Type I error rate and optimize performance. Simulations show that the design is robust under a wide variety of different scenarios. When two or more subgroups are truly homogeneous but differ from the other subgroups, the proposed method is substantially more powerful than tests that either ignore subgroups or conduct a separate test within each subgroup. Supplementary materials for this article are available online.

Entities:  

Keywords:  Bayesian analysis; Group sequential; Piecewise exponential model; Randomized comparative trial; Response heterogeneity; Survival comparison

Year:  2020        PMID: 35582047      PMCID: PMC9109248          DOI: 10.1080/01621459.2020.1837142

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   4.369


  35 in total

1.  Design and analysis of group sequential clinical trials with multiple primary endpoints.

Authors:  Michael R Kosorok; Shi Yuanjun; David L DeMets
Journal:  Biometrics       Date:  2004-03       Impact factor: 2.571

2.  Adaptive enrichment designs for confirmatory trials.

Authors:  Tze Leung Lai; Philip W Lavori; Ka Wai Tsang
Journal:  Stat Med       Date:  2018-09-11       Impact factor: 2.373

3.  Bayesian non-parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantation.

Authors:  Yanxun Xu; Peter F Thall; William Hua; Borje S Andersson
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-12-16       Impact factor: 1.864

4.  Heterogeneity in survival analysis.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1988-11       Impact factor: 2.373

5.  A multiple testing procedure for clinical trials.

Authors:  P C O'Brien; T R Fleming
Journal:  Biometrics       Date:  1979-09       Impact factor: 2.571

6.  Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes.

Authors:  Catrin Tudur Smith; Paula R Williamson; Anthony G Marson
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

7.  Bayesian nonparametric nonproportional hazards survival modeling.

Authors:  Maria De Iorio; Wesley O Johnson; Peter Müller; Gary L Rosner
Journal:  Biometrics       Date:  2009-02-04       Impact factor: 2.571

8.  Bayesian adaptive model selection for optimizing group sequential clinical trials.

Authors:  J Kyle Wathen; Peter F Thall
Journal:  Stat Med       Date:  2008-11-29       Impact factor: 2.373

Review 9.  The challenge of intratumour heterogeneity in precision medicine.

Authors:  J Seoane; L De Mattos-Arruda
Journal:  J Intern Med       Date:  2014-07       Impact factor: 8.989

10.  Familywise error control in multi-armed response-adaptive trials.

Authors:  D S Robertson; J M S Wason
Journal:  Biometrics       Date:  2019-04-03       Impact factor: 2.571

View more
  1 in total

1.  BIPSE: A biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpoint.

Authors:  Beibei Guo; Yong Zang
Journal:  Stat Med       Date:  2021-11-25       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.